153 related articles for article (PubMed ID: 27484124)
1. Measuring the burden of preventable diabetic hospitalisations in the Mexican Institute of Social Security (IMSS).
Lugo-Palacios DG; Cairns J; Masetto C
BMC Health Serv Res; 2016 Aug; 16():333. PubMed ID: 27484124
[TBL] [Abstract][Full Text] [Related]
2. [Direct service costs of diabetes mellitus hospitalisations in the Mexican Institute of Social Security].
Salas-Zapata L; Palacio-Mejía LS; Aracena-Genao B; Hernández-Ávila JE; Nieto-López ES
Gac Sanit; 2018; 32(3):209-215. PubMed ID: 27495830
[TBL] [Abstract][Full Text] [Related]
3. The financial and health burden of diabetic ambulatory care sensitive hospitalisations in Mexico.
Lugo-Palacios DG; Cairns J
Salud Publica Mex; 2016; 58(1):33-40. PubMed ID: 26879505
[TBL] [Abstract][Full Text] [Related]
4. Hospital care direct costs due to ambulatory care sensitive conditions related to diabetes mellitus in the Mexican public healthcare system.
Saturno-Hernández P; Moreno-Zegbe E; Poblano-Verastegui O; Torres-Arreola LDP; Bautista-Morales AC; Maya-Hernández C; Uscanga-Castillo JD; Flores-Hernández S; Gómez-Cortez PM; Vieyra-Romero WI
BMC Health Serv Res; 2024 Apr; 24(1):507. PubMed ID: 38659025
[TBL] [Abstract][Full Text] [Related]
5. [Direct costs of medical care for patients with type 2 diabetes mellitus in Mexico micro-costing analysis].
Rodríguez Bolaños Rde L; Reynales Shigematsu LM; Jiménez Ruíz JA; Juárez Márquezy SA; Hernández Ávila M
Rev Panam Salud Publica; 2010 Dec; 28(6):412-20. PubMed ID: 21308167
[TBL] [Abstract][Full Text] [Related]
6. Medical Expenditure for Chronic Diseases in Mexico: The Case of Selected Diagnoses Treated by the Largest Care Providers.
Figueroa-Lara A; Gonzalez-Block MA; Alarcon-Irigoyen J
PLoS One; 2016; 11(1):e0145177. PubMed ID: 26744844
[TBL] [Abstract][Full Text] [Related]
7. Costs of diabetes and its complications in Poland.
Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
[TBL] [Abstract][Full Text] [Related]
8. 10 years Analysis of Diabetes-related Major Lower Extremity Amputations in Mexico.
Ascencio-Montiel IJ
Arch Med Res; 2018 Jan; 49(1):58-64. PubMed ID: 29680306
[TBL] [Abstract][Full Text] [Related]
9. [The cost of diabetes in Latin America: evidence from Mexico].
Arredondo A; De Icaza E
Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
[TBL] [Abstract][Full Text] [Related]
10. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].
Arredondo A
Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108
[TBL] [Abstract][Full Text] [Related]
11. Assessing health system performance: effective coverage at the Mexican Institute of Social Security.
Leslie HH; Doubova SV; Pérez-Cuevas R
Health Policy Plan; 2019 Nov; 34(Supplement_2):ii67-ii76. PubMed ID: 31723962
[TBL] [Abstract][Full Text] [Related]
12. Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in Mexico.
Arredondo A; de Icaza E
Diabetologia; 2009 Aug; 52(8):1693-5. PubMed ID: 19504083
[No Abstract] [Full Text] [Related]
13. [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study].
Köster I; Hauner H; von Ferber L
Dtsch Med Wochenschr; 2006 Apr; 131(15):804-10. PubMed ID: 16607599
[TBL] [Abstract][Full Text] [Related]
14. Diabetes care innovation in the Mexican Institute for Social Insurance: Scaling up the preventive chronic disease care model to address critical coverage constraints.
González Block MÁ; Díaz Portillo SP; Morales HR; Rodríguez Saldaña J; Gutiérrez Calderón E
Prim Care Diabetes; 2021 Apr; 15(2):314-322. PubMed ID: 33199194
[TBL] [Abstract][Full Text] [Related]
15. Health disparities from economic burden of diabetes in middle-income countries: evidence from México.
Arredondo A; Reyes G
PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629
[TBL] [Abstract][Full Text] [Related]
16. Health and economic impact associated with rheumatoid arthritis discharges: a cost analysis of a two-year cohort in Mexico.
Mendoza-Gutierrez CF; Montiel-Ojeda D; Vargas-Chanes D; Cisneros-González N; Fernández-Gárate JE; Godina-Ortiz B; Clark P
BMC Health Serv Res; 2023 Nov; 23(1):1320. PubMed ID: 38031120
[TBL] [Abstract][Full Text] [Related]
17. The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory.
Pagano E; De Rosa M; Rossi E; Cinconze E; Marchesini G; Miccoli R; Vaccaro O; Bonora E; Bruno G
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):944-50. PubMed ID: 27289165
[TBL] [Abstract][Full Text] [Related]
18. A cost-benefit analysis of the Mexican Social Security Administration's family planning program.
Nortman DL; Halvas J; Rabago A
Stud Fam Plann; 1986; 17(1):1-6. PubMed ID: 3083537
[TBL] [Abstract][Full Text] [Related]
19. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.
Arredondo A; Zúñiga A
Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974
[TBL] [Abstract][Full Text] [Related]
20. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.
Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A
Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
